These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30123835)

  • 1. Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.
    Prosser LA; Lam KK; Grosse SD; Casale M; Kemper AR
    MDM Policy Pract; 2018; 3(1):. PubMed ID: 30123835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health and economic outcomes of newborn screening for infantile-onset Pompe disease.
    Richardson JS; Kemper AR; Grosse SD; Lam WKK; Rose AM; Ahmad A; Gebremariam A; Prosser LA
    Genet Med; 2021 Apr; 23(4):758-766. PubMed ID: 33281187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations.
    Kemper AR; Hwu WL; Lloyd-Puryear M; Kishnani PS
    Pediatrics; 2007 Nov; 120(5):e1327-34. PubMed ID: 17974725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Timely Needs for Infantile Onset Pompe Disease Newborn Screening-Practice in Taiwan.
    Chiang SC; Chien YH; Chang KL; Lee NC; Hwu WL
    Int J Neonatal Screen; 2020 Jun; 6(2):30. PubMed ID: 33073026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation.
    Hale K; Kellar-Guenther Y; McKasson S; Singh S; Ojodu J
    Int J Neonatal Screen; 2020 Jun; 6(2):48. PubMed ID: 33073038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public support for neonatal screening for Pompe disease, a broad-phenotype condition.
    Weinreich SS; Rigter T; van El CG; Dondorp WJ; Kostense PJ; van der Ploeg AT; Reuser AJ; Cornel MC; Hagemans ML
    Orphanet J Rare Dis; 2012 Mar; 7():15. PubMed ID: 22413814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The First Year Experience of Newborn Screening for Pompe Disease in California.
    Tang H; Feuchtbaum L; Sciortino S; Matteson J; Mathur D; Bishop T; Olney RS
    Int J Neonatal Screen; 2020 Mar; 6(1):9. PubMed ID: 33073007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States.
    Ross LF; Clarke AJ
    Pediatr Neurol; 2017 Dec; 77():12-22. PubMed ID: 29079012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening.
    Chien YH; Goldstein JL; Hwu WL; Smith PB; Lee NC; Chiang SC; Tolun AA; Zhang H; Vaisnins AE; Millington DS; Kishnani PS; Young SP
    JIMD Rep; 2015; 19():67-73. PubMed ID: 25681082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn Screening for Pompe Disease.
    Bodamer OA; Scott CR; Giugliani R;
    Pediatrics; 2017 Jul; 140(Suppl 1):S4-S13. PubMed ID: 29162673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Initial Evaluation of Patients After Positive Newborn Screening: Recommended Algorithms Leading to a Confirmed Diagnosis of Pompe Disease.
    Burton BK; Kronn DF; Hwu WL; Kishnani PS;
    Pediatrics; 2017 Jul; 140(Suppl 1):S14-S23. PubMed ID: 29162674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Newborn Screening the Ultimate Strategy to Reduce Diagnostic Delays in Pompe Disease? The Parent and Patient Perspective.
    Saich R; Brown R; Collicoat M; Jenner C; Primmer J; Clancy B; Holland T; Krinks S
    Int J Neonatal Screen; 2020 Mar; 6(1):1. PubMed ID: 33073001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for Pompe disease: an update, 2011.
    Burton BK
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Murmur in a Boy with Normal Paternal Prenatal Carrier Screening for Pompe Disease.
    Jay AM; Anne P; Stockton D
    Case Rep Pediatr; 2019; 2019():6274979. PubMed ID: 31915562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Genetic Counseling in Pompe Disease After Patients Are Identified Through Newborn Screening.
    Atherton AM; Day-Salvatore D;
    Pediatrics; 2017 Jul; 140(Suppl 1):S46-S50. PubMed ID: 29162676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease.
    Umapathysivam K; Hopwood JJ; Meikle PJ
    Clin Chem; 2001 Aug; 47(8):1378-83. PubMed ID: 11468225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Qualitative Study: Mothers' Experiences of Their Child's Late-Onset Pompe Disease Diagnosis Following Newborn Screening.
    Crossen K; Berry L; Myers MF; Leslie N; Goueli C
    Int J Neonatal Screen; 2022 Jul; 8(3):. PubMed ID: 35892473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing Pompe Disease Newborn Screening: The Role of Industry.
    Keutzer JM
    Int J Neonatal Screen; 2020 Sep; 6(3):55. PubMed ID: 33123636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
    Kishnani PS; Beckemeyer AA; Mendelsohn NJ
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
    Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.